Today, more than ever, antibiotics are to be considered a prized resource for the protection of our health and in general for the advancement and results achieved by modern medicine. Antimicrobial resistance is a wide-ranging phenomenon that also includes antibiotic resistance: “If no action is taken by 2050, antimicrobial resistance will kill more people every year than cancer.” AMR is therefore a problem that regards us all: it can affect anyone at any stage of life and new forms of resistance can easily spread between continents with the movements of people, freights and animals. With few replacement drugs currently in the pipeline, without coordinated and immediate activities on a global scale, the world is heading towards a post-antibiotic era in which common infections could again become lethal.

Polk&Union supports digital education on AMR

The Menarini Group has decided to take an active part in the fight against antimicrobial-resistance by expanding its product portfolio and recently adding three innovative antibiotics. Polk&Union has supported the Infection Disease business unit run by Menarini Group with the aim of fostering this commitment: first of all through a digital education operation they want to inform and to raise awareness amongst the general public and healthcare professionals, providing accurate information on the threat posed by this situation and on the importance of responsible antibiotic use.